Hexamer Therapeutics Inc.
Pullman, WA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2345 NE Hopkins Ct b, Pullman, WA 99163, USA
- Website
- hexamertherapeutics.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $3,928,061 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Research and development services BA230121 titled self assembling vaccine platform | Defense Health Agency | $3,928,061 |
Quick answers
Is Hexamer Therapeutics Inc. registered in SAM.gov?
Yes. Hexamer Therapeutics Inc.'s SAM.gov registration is active through July 7, 2027.
What is Hexamer Therapeutics Inc.'s CAGE code?
Hexamer Therapeutics Inc.'s CAGE code is 9CUB9, and its Unique Entity ID (UEI) is MK8HSFMVB647.
How much has Hexamer Therapeutics Inc. received in federal contracts?
Federal contracts obligated $3,928,061 to Hexamer Therapeutics Inc. in fiscal years 2023 through 2027.
What is Hexamer Therapeutics Inc.'s most recent federal award?
Hexamer Therapeutics Inc.'s most recent federal contract award is Research and development services BA230121 titled self assembling vaccine platform (HT942523C0078), from Defense Health Agency, on September 29, 2023.
On GovTribe
See Hexamer Therapeutics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors